Insider · CIK 0001513026

Eller Mark G.

Reports to the SEC for 1 company · PALO ALTO, CA

Transactions

Companies

Filings

CIK

0001513026

Forms 4 and 5

Insider transactions

4 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-08-13	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Research & Clinical Dev.	MExercise/Conversion	+690 sh	—	—	4,151
2011-08-13	JAZZJazz Pharmaceuticals plc · Restricted Stock UnitsM Exercise/Conversion	SVP, Research & Clinical Dev.	MExercise/Conversion	−690 sh	—	—	0
2011-05-31	JAZZJazz Pharmaceuticals plcJ Other	SVP, Research & Clinical Dev.	JOther	+3,461 sh	$0.85	+$2,941.85	3,461
2011-03-10	JAZZJazz Pharmaceuticals plc · Option (right to buy)A Award	SVP, Research & Clinical Dev.	AAward	+30K sh	—	—	30,000

C/O JAZZ PHARMACEUTICALS, INC. 3180 PORTER DRIVE

PALO ALTO, CA, 94304